Hygea Healthcare (6078.HK): Performance is in line with expectations, and bed expansion is progressing steadily
Hygea Healthcare (6078.HK): Strong management resilience and gradual entry into the harvest period
GF Securities: Target price of HK$38.81 for a “buy” rating for Hygea Healthcare (06078)
Hygea Healthcare (6078.HK) 2023 performance review: Successful hospital acquisition and integration, optimistic about 24-year performance growth
Hygea (6078.HK): The release of bed capacity due to mergers and acquisitions of high-quality hospitals is expected to accelerate
Hygea Healthcare (06078.HK): Merger and acquisition integration benefits highlight regional advantages and further strengthen brand influence
Hygea Healthcare (6078.HK): FY23 meets expectations FY24 endogenous epitaxial drives high growth, and the operating conditions of the new hospital continue to improve
Hygea Healthcare (6078.HK): Endogenous growth combined with epitaxial expansion will maintain rapid growth in revenue
Hygea Healthcare (06078.HK) Hong Kong Stock Company Information Update Report: Rapid Performance Growth in 2023, Endogenous and External Growth Continues to Advance
Hygea Healthcare (06078.HK): Acquisition of hospitals increased significantly, and 2024 results can be expected
Hygea Healthcare (06078.HK): Healthy growth in hospital business, self-built mergers and acquisitions continue to advance
HYGEIA HEALTH(06078.HK):SOLID PERFORMANCE OF HOSPITAL BUSINESS
Hygea Healthcare (6078.HK): The hospital is growing steadily, and the second phase of the new merger and acquisition is ready to go
Hygea Healthcare (6078.HK): High base highlights management resilience and the integration of new hospitals is progressing smoothly
Nomura Adjusts Hygeia Healthcare Holdings's Price Target to HK$58.20 From HK$70.39, Keeps at Buy
Bank of China International: Maintaining Hygea Healthcare's (06078) “Buy” Rating Target Price Reduced to HK$47
Hygea Healthcare (6078.HK): Performance growth guidelines have been lowered, but growth prospects for next year and the medium to long term are still steady; target price reduction
Hygea Healthcare (6078.HK): Expected costs for the second half of the year slightly exceed expectations and adjust target prices
Hygea Healthcare (6078.HK): Results for the second half of the year are expected to exceed expectations
Hygeia Healthcare (6078.HK) Bank International Medical Industry Business Day 2023: Rapid revenue growth in 3Q23, increase target price
No Data